Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | FNTA | P49354 | 3/20 | 0.39 |
| ▸ | FNTB | P49356 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.37 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.36 |
| ▸ | IP6K1 | Q92551 | 1/20 | 0.35 |
| ▸ | IP6K3 | Q96PC2 | 1/20 | 0.35 |
| ▸ | IP6K2 | Q9UHH9 | 1/20 | 0.35 |
| ▸ | MARS1 | P56192 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6776515 | 0.82 | FNTA (0.39) | FNTAFNTBTDP1PGGT1BMARS1 | |
| SCHEMBL6624888 | 0.80 | FNTA (0.44) | FNTAFNTBTDP1PGGT1BMARS1 | |
| SCHEMBL6775076 | 0.80 | FNTA (0.38) | FNTAFNTBTDP1PGGT1BMARS1 | |
| SCHEMBL7140058 | 0.80 | FNTA (0.56) | FNTAFNTBTDP1PGGT1B | |
| SCHEMBL6772100 | 0.80 | FNTA (0.56) | FNTAFNTBTDP1PGGT1B | |
| SCHEMBL6672023 | 0.80 | NPC1 (0.44) | FNTAFNTBTDP1PGGT1B | |
| SCHEMBL6624627 | 0.80 | FNTA (0.57) | FNTAFNTBTDP1PGGT1B | |
| SCHEMBL6627025 | 0.80 | FNTA (0.57) | FNTAFNTBTDP1PGGT1B | |
| SCHEMBL8608789 | 0.80 | FNTA (0.44) | FNTAFNTBTDP1PGGT1BMARS1 | |
| SCHEMBL6777404 | 0.78 | KMT2A (0.48) | FNTAFNTBTDP1PGGT1BMARS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6693123-B2 | (4-(3-PYRIDYLAMINOMETHYLENE)-2-PHENYLBENZOYL)-N -METHYLMETHIONINE, METHYL ESTER FOR EXAMPLE; RESTENOSIS, HYPERPLASIA | UNIVERSITY OF PITTSBURGH | 2004-02-17 | — | — | US | disclosed |